Management and Reconfiguration of a Radiology Department under the Threat of Coronavirus Disease 2019: Experience from W
- PDF / 602,922 Bytes
- 6 Pages / 595.276 x 841.89 pts (A4) Page_size
- 53 Downloads / 146 Views
40(4):1-6,2020
1
Management and Reconfiguration of a Radiology Department under the Threat of Coronavirus Disease 2019: Experience from Wuhan Meng TIAN1†, Cong-cong LIU1†, Lu LONG2#, Qiu-xia WANG1# 1 Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China 2 Department of Epidemiology and Biostatistics, West China School of Public Health, Sichuan University, Chengdu 610000, China Huazhong University of Science and Technology 2020
Summary: The corona virus disease 2019 (COVID-19) is an emerging respiratory infectious disease caused by SARS-CoV-2, which first occurred in December 2019 in Wuhan, China. These days, in China, chest CT is used for diagnosis of COVID-19, as an important complement to the reverse-transcription polymerase chain reaction (RT-PCR) test. Because of contacting with a large number of suspected or probable cases closely during chest CT examination, radiographers are easily infected with COVID-19. This article included the rearrangement of CT examination room in fever clinic, the rearrangement of human resources in radiology department, and the drafting of new operating procedures for radiologists who carry out CT examination on COVID-19 patients. This article also introduced the emergency management procedures of the department of radiology during the outbreak, and the experience of infection prevention for the staff of the department of radiology. Key words: COVID-19; management; reconfiguration; radiology department
In December 2019, a new viral pneumonia case occurred in Wuhan, Hubei Province. Because it is a respiratory disease that has never been experienced before and has a wide and rapid infection ability, it has attracted the attention of all countries in the world[1, 2]. High-throughput sequencing has revealed a novel beta coronavirus, which is similar to severe acute respiratory syndrome coronavirus (SARS-CoV)[3]. As of March 2020, 193 475 confirmed human cases of infection with corona virus disease 2019 (COVID-19) including 7864 deaths had been reported from 164 countries[4]. Patients with uncomplicated upper respiratory tract viral infection, may have non-specific symptoms such as fever, fatigue and dry cough. The diagnosis of COVID-19 is based on epidemiological history, clinical manifestation and laboratory examination results. Routine confirmation of cases of COVID-19 is based on detection of unique sequences of virus RNA by nucleic acid amplification tests (NAAT) such as real-time reverse transcription polymerase chain reaction (rRT-PCR) with confirmation by nucleic acid Meng TIAN, E-mail: [email protected]; Cong-cong LIU, E-mail: [email protected] † The authors contributed equally to this work. # Corresponding authors, Lu LONG, E-mail: longlu201609@ 163.com; Qiu-xia WANG, E-mail: [email protected]
sequencing when necessary[5]. However, with the limitations of sample collection, transportation, and kit performance, the total positive rate of RT-PCR for throat swab samples was reported to b
Data Loading...
